Core Laboratories Inc. Files 8-K on Financials
Ticker: CLB · Form: 8-K · Filed: Jul 24, 2024 · CIK: 1958086
Sentiment: neutral
Topics: financial-reporting, sec-filing
TL;DR
CORE filed an 8-K on July 24th detailing financial results and disclosures.
AI Summary
Core Laboratories Inc. /DE/ filed an 8-K on July 24, 2024, reporting on its Results of Operations and Financial Condition, Regulation FD Disclosure, and Financial Statements and Exhibits. The filing details information related to the company's financial performance and disclosures, as required by the SEC.
Why It Matters
This filing provides investors with crucial updates on Core Laboratories' financial health and operational status, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial disclosure filing (8-K) and does not contain specific new material events that would inherently increase risk.
Key Players & Entities
- Core Laboratories Inc. /DE/ (company) — Registrant
- July 24, 2024 (date) — Date of Report
- 6316 Windfern Road, Houston, TX 77040 (address) — Principal Executive Offices
- 713-328-2673 (phone_number) — Registrant's Telephone Number
FAQ
What is the primary purpose of this Form 8-K filing?
The primary purpose of this Form 8-K filing is to report on the Results of Operations and Financial Condition, Regulation FD Disclosure, and Financial Statements and Exhibits of Core Laboratories Inc. /DE/.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on July 24, 2024.
What is the state of incorporation for Core Laboratories Inc.?
Core Laboratories Inc. is incorporated in Delaware.
What is the business address of Core Laboratories Inc.?
The business address of Core Laboratories Inc. is 6316 Windfern Road, Houston, TX 77040.
What is the SIC code for Core Laboratories Inc.?
The Standard Industrial Classification (SIC) code for Core Laboratories Inc. is OIL, GAS FIELD SERVICES, NBC [1389].
Filing Stats: 545 words · 2 min read · ~2 pages · Grade level 9.9 · Accepted 2024-07-24 16:37:48
Key Financial Figures
- $0.01 — ch registered Common Stock (par value $0.01) CLB New York Stock Exchange Indi
Filing Documents
- clb-20240724.htm (8-K) — 48KB
- clb-ex99_1.htm (EX-99.1) — 642KB
- img77179564_0.jpg (GRAPHIC) — 4KB
- 0000950170-24-086092.txt ( ) — 845KB
- clb-20240724.xsd (EX-101.SCH) — 31KB
- clb-20240724_htm.xml (XML) — 4KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On July 24, 2024, Core Laboratories Inc. issued a press release announcing its financial results for the second quarter of 2024.
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On July 24, 2024, Core Laboratories Inc. issued a press release announcing a quarterly cash dividend of $0.01 per share of common stock for shareholders of record on August 5, 2024 and payable August 26, 2024. The full text of the press release is set forth in Exhibit 99.1 attached hereto. The information in this Report and the exhibit attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly stated by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits 99.1 Press release issued on July 24, 2024 * 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). * This exhibit is intended to be furnished and shall not be deemed "filed" for purposes of the Exchange Act.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Core Laboratories Inc. Dated: July 24, 2024 By /s/ Christopher S. Hill Christopher S. Hill Chief Financial Officer